Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia
| Image |  |
|---|---|
| Description | scientific article published on 05 June 2010 |
| Author/s | |
| Publication date | June 5, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |